Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Mar;86(3):256-308.
doi: 10.1016/j.jinf.2022.12.027. Epub 2022 Dec 31.

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

Catia Cillóniz  1 , Anna Motos  2 , Tatiana Castañeda  3 , Albert Gabarrús  4 , Ferran Barbé  5 , Antoni Torres  6 ; CIBERESUCICOVID Project (COV20/00110, ISCIII)
Collaborators, Affiliations
Observational Study

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

Catia Cillóniz et al. J Infect. 2023 Mar.
No abstract available

Keywords: COVID-19; Critically ill patients; Intensive care; Outcomes; Remdesivir.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig 1
Fig. 1
Flowchart of the study population.
See this image and copyright information in PMC

References

    1. Kelly Ansems, Felicitas Grundeis, Karolina Dahms, Agata Mikolajewska, Volker Thieme, Vanessa Piechotta, et al. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021;8 doi: 10.1002/14651858.CD014962. - DOI - PMC - PubMed
    1. Kemp Steven A., Collier Dami A., Datir Rawlings P., Ferreira Isabella A.T.M., Salma Gayed, Aminu Jahun, et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592(7853):277–282. doi: 10.1038/s41586-021-03291-y. - DOI - PMC - PubMed
    1. Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022;606(7914):585–593. doi: 10.1038/s41586-022-04802-1. - DOI - PMC - PubMed
    1. Leisman Daniel E., Lukas Ronner, Rachel Pinotti, Taylor Matthew D., Pratik Sinha, Calfee Carolyn S., et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8(12):1233–1244. doi: 10.1016/S2213-2600(20)30404-5. - DOI - PMC - PubMed
    1. Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S, et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022;607(7917):97–103. doi: 10.1038/s41586-022-04576-6. - DOI - PMC - PubMed